Antioxidants (Basel). 2020 Jul; 9(7): 624.Published online 2020 Jul 16. doi: 10.3390/antiox9070624PMCID: PMC7402141PMID: 32708578Francesca Silvagno,* Annamaria Vernone, and Gian Piero PescarmonaAuthor information Article notes Copyright and License information DisclaimerThis article has been cited by other articles in PMC. Go to:AbstractThe novel COVID-19 pandemic is affecting the world’s population differently: mostly in the presence of conditions such as aging, diabetes and hypertension the virus triggers a lethal cytokine storm and patients die from acute respiratory distress syndrome, whereas in many cases the disease has a mild or even asymptomatic progression. A common denominator in all conditions associated with COVID-19 appears...
